medigraphic.com
Anales de la Sociedad Mexicana de Oftalmología y Archivos de la Asociación Para Evitar la Ceguera en México

2003, Number 4

<< Back Next >>

Rev Mex Oftalmol 2003; 77 (4)

Rosácea ocular

De La Luz-Hosannilla JC, Rivera-Sempértegui JO, Hernández-Quintela E, Naranjo-Tackman R

Language: Spanish
References: 22
Page: 134-139
PDF size: 537.99 Kb.


ABSTRACT

Purpose: To determine the prevalence of ocular rosacea in the "Dr. Luis Sánchez Bulnes" Hospital of the Asociación Para Evitar la Ceguera en México (APEC), and to evaluate the frequency of signs and treatment most used.
Design: A retrospective, transversal and descriptive study. A longitudinal phase was included to evaluate visual acuity
Methods: A retrospective review of the clinical records of patients with ocular rosacea from the "Dr. Luis Sánchez Bulnes" Hospital APEC from January 1994 to June 2001, were included. The variables captured included: gender, age, chief complain, initial and final best corrected visual acuity, clinical signs and treatment.
Results: From a total of 333,752 clinical records in the hospital data base 50 had the diagnosis of ocular rosacea. Sixty eight percent were female and 32% male. It was more frequent in 46 years old or older. The chief complain was foreign body sensation (42%), followed by itching (24%), red eye (14%), blurred vision (12%) and tearing (8%). Fifty eight percent of subjects had a initial visual acuity from count fingers at 4 m to 4/10. Best corrected visual acuity improved in 70% of cases, 80% had corneal peripheral vascularization, 80% presented corneal leucoma, 92% had cutaneous involvement characterized by telangiectasias, diffuse thickness of the eye lid and malar erythema, 94% presented meibomianitis and lacrimal film instability, 94% received topical and 80% systemic treatment, being the tetracyclines the most used, 34% of subjects had anti-inflammatory treatment, steroids were more frequently prescribed.
Conclusions: Ocular rosacea had a prevalence of 0,015% in the "Dr. Luis Sánchez Bulnes" Hospital. The most frequent chief complain was foreign body sensation; the clinical signs most frequently found were meibomianitis, peripheral corneal vascularization, peripheral corneal leucoma and cutaneous involvement. Tetracyclines were the drugs most frequently used.


REFERENCES

  1. Akpek EK, Merchant A: Ocular Rosacea: patient characteristics and follow-up. Ophthalmology 1997; 104:1863-1867.

  2. Jenkins MS, Bown SI y cols.: Ocular Rosacea. Am J Ophthalmol 1979; 88:618-622.

  3. Zengin N, Tol H y cols.: Meibomian gland dysfunction and tear film abnormalities in rosacea. Cornea 1995; 14 (2): 144-146.

  4. Erzurum SA, Feder RS y cols.: Acne rosacea with keratitis in childhood. Arch Ophthalmol 1993; 111.

  5. Browning DJ, Rosenwasser G, Lugo M: Ocular rosacea in blacks. Am J Ophthalmol 1986; 101:441-444.

  6. Borrie P: Rosacea with special reference to its ocular manifestations. Br J Dermatol 1953; 65:448-457.

  7. Wise G: Ocular rosacea. Am J Ophthalmol 1943; 26:591-609.

  8. Lempert SL, Jenkins MS, Brown SI: Chalazia and rosacea. Arch Ophthalmol 1979; 97:1652-1653.

  9. Brown SI, Shahinian L: Diagnosis and treatment of ocular rosacea. Ophthalmology 1978; 85:779-786.

  10. Lemp MA, Mahmood M, Weiler HH: Association of rosacea and keratoconjunctivitis sicca. Arch Ophthalmol 1984; 102:556-557.

  11. Gudmundsen KJ, O’Donnell BF, Powell FC: Schirmer testing for dry eyes in patients with rosacea. J Am Acad Dermatol 1992; 26:211-214.

  12. Zengin N: The effect of dacryocystorhinostomy on tear film flow and stability in patients with chronic dacryocystitis. Acta Ophthalmol 1993; 76:714-716.

  13. Alfonso AA, Sobrin L y cols.: Tear fluid gelatinase B activity correlates with Il-alfa concentration and fluorescein clearence in ocular rosacea. Ophthalmol Vis Sci 1999; 40:2506-2512.

  14. Hoang-Xuan T, Rodríguez A, Zaltas MM y cols.: Ocular rosacea. A histologic and inmunopathologic study. Ophthalmology 1990; 97:1468-1475.

  15. Barnhorst DA, Foster JA y cols.: The efficacy of topical metronidazole in the treatment of ocular rosacea. Ophthalmology 1996; 103:1880-1883.

  16. Greiner JV, Korb DR: Increase in tear film lipid layer thickness following treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci 1993; 34 (supl 91):1469.

  17. Frucht-Pery J, Sagi E, Hemo I, Ever-Hadani P: Efficacy of doxycycline and tetracycline in ocular rosacea. Am J Ophthalmol 1993;116:88-92.

  18. Knight AG, Vickers CFH: A follow-up of tetracycline-treated rosacea. Br J Dermatol 1975; 93:577-580.

  19. McCully JP, Dougherty JM, Deneau DG: Classification of chronic blepharitis. Ophthalmology 1982; 89:1173-1180.

  20. Marks R, Ellis J: Comparative efectiveness of tetracicline and ampicillin in rosacea. Lancet 1971; 2:1049-1052.

  21. Hardten DR, Lima PH, Schmidt BJ, Nelson JD: In vitro evaluation of the effects of metronidazole on rabbit corneal epithelial cells. Cornea 1994; 13:259-63.

  22. Browning DJ, Proia AD: Ocular rosacea. Surv Ophthalmol 1986; 31:145-58.




2020     |     www.medigraphic.com